Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical Atherosclerosis in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study

Background: Some patients experience statin-induced side effects or prefer nutraceutical approaches for the treatment of dyslipidemia. This has led to a search for alternative therapeutic approaches for dyslipidemia management. In recent studies Citrus bergamia (known as Bergamot) juice was able to...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Pharmacol
Asıl Yazarlar: Toth, Peter P., Patti, Angelo M., Nikolic, Dragana, Giglio, Rosaria V., Castellino, Giuseppa, Biancucci, Teresa, Geraci, Fabiana, David, Sabrina, Montalto, Giuseppe, Rizvi, Ali, Rizzo, Manfredi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2016
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4702027/
https://ncbi.nlm.nih.gov/pubmed/26779019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2015.00299
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller